Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CGEM | BCAX |
|---|---|---|
| Price | $15.63 | $16.42 |
| Change today | ▼ 3.82% | ▼ 0.85% |
| Market cap | $1.01B | $1.09B |
| Return, 3 months | -15.0% | -44.7% |
| Return, year to date | +51.0% | -2.4% |
| Return, 1 year | +142.3% | -8.8% |
| P/E (TTM) | -5.0 | -5.3 |
| P/B | 3.1 | 2.3 |
| P/E percentile vs own 5y | 33rd | 98th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | +23.3% | -102.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -50.3% | -41.0% |
| Analyst target vs. price | +126.0% | +123.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 36 | 20 |
| 30-day volatility | 85.4% | 43.7% |
| Max drawdown, 1 year | -36.7% | -46.0% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
